Follow
Ahmet Emre Eşkazan
Ahmet Emre Eşkazan
Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine
Verified email at istanbul.edu.tr - Homepage
Title
Cited by
Cited by
Year
Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature
T Soysal, A Salihoğlu, SN Esatoğlu, E Gültürk, AE Eşkazan, G Hatemi, ...
Rheumatology 53 (6), 1136-1141, 2014
542014
Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
RM Stone, RA Larson, H Doehner
The New England journal of medicine 377 (19), 1903-1903, 2017
502017
Dasatinib‐induced pulmonary arterial hypertension
N Özgür Yurttaş, AE Eşkazan
British Journal of Clinical Pharmacology 84 (5), 835-845, 2018
452018
Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura
AE Eskazan
Annals of hematology 95 (11), 1751-1756, 2016
452016
COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature
A Murt, AE Eskazan, U Yılmaz, T Ozkan, MC Ar
Journal of medical virology, 2021
442021
Spondylodiscitis: evaluation of patients in a tertiary hospital
S Kaya, S Ercan, S Kaya, U Aktas, K Kamasak, H Ozalp, K Cinar, ...
The Journal of Infection in Developing Countries 8 (10), 1272-1276, 2014
412014
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion
AE Eskazan, D Eyice, EA Kurt, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, ...
Leukemia Research 38 (7), 781-787, 2014
392014
Acute acalculous cholecystitis due to viral hepatitis A
S Kaya, AE Eskazan, N Ay, B Baysal, MV Bahadir, A Onur, R Duymus
Case reports in infectious diseases 2013, 2013
352013
Diyarbakır Eğitim Araştırma Hastanesi sağlık çalışanlarında kesici delici alet yaralanmalarının değerlendirilmesi
Ş Kaya, B Baysal, AE Eşkazan, H Çolak
Viral Hepatit Dergisi 18 (3), 107-10, 2012
352012
Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
D Keskin, S Sadri, AE Eskazan
Drug design, development and therapy 10, 3355, 2016
342016
Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy
AE Eskazan, T Soysal, S Ongoren, E Gulturk, B Ferhanoglu, Y Aydin
Haematologica 96 (3), e15, 2011
322011
New drugs approved for acute myeloid leukaemia in 2018
S Kucukyurt, AE Eskazan
British Journal of Clinical Pharmacology 85 (12), 2689-2693, 2019
302019
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
T Elverdi, AE Eskazan
Drug design, development and therapy 13, 1251, 2019
272019
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data …
S Ongoren, AE Eskazan, V Suzan, S Savci, I Erdogan Ozunal, S Berk, ...
Hematology 23 (4), 212-220, 2018
262018
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate
AE Eskazan, M Ayer, B Kantarcioglu, D Arica, N Demirel, D Aydin, ...
British journal of haematology 167 (1), 139-141, 2014
262014
Generics in chronic myeloid leukemia: current arguments for and against and the established evidence
T Soysal, AE Eskazan, MC Ar
Expert Review of Hematology 7 (6), 697-699, 2014
252014
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
AE Eskazan, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, S Ongoren Aydin, ...
Leukemia & Lymphoma 55 (12), 2935-2937, 2014
252014
The impact of BCR‐ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia
A Ercaliskan, AE Eskazan
Cancer 124 (19), 3806-3818, 2018
242018
Brucellar pericarditis: a report of four cases and review of the literature
S Kaya, AE Eskazan, N Elaldi
International Journal of Infectious Diseases 17 (6), e428-e432, 2013
242013
Outcomes of chronic myeloid leukemia patients with early molecular response at 3 and 6 months: a comparative analysis of generic imatinib and glivec
AE Eskazan, S Sadri, D Keskin, M Ayer, B Kantarcioglu, N Demirel, ...
Clinical Lymphoma Myeloma and Leukemia 17 (12), 804-811, 2017
232017
The system can't perform the operation now. Try again later.
Articles 1–20